Skip to main content
. 2022 Sep 22;7:31–42. doi: 10.1016/j.ijregi.2022.09.007

Table 3.

Secondary outcome parameters in Group A, Group B and Group C

Secondary outcome parameters High-dose Corticosteroid Recipient Low-moderate dose Corticosteroid Recipient p value
Group A
Length of stay (median [IQR]) 13.00 [8.00, 17.00] 14.00 [11.00, 20.00] 0.01
ICU admission (%) 57 (95.0) 45 (83.3) 0.0i65
Invasive Ventilation (%) 31 (51.7) 18 (33.3) 0.059
Non-Invasive ventilation (BIPAP/HFNO) (%) 30 (50.0) 33 (61.1) 0.262
Face mask/O2 cannula (%) 2 (3.3) 3 (5.6) 0.666
Group B
Length of stay (median [IQR]) 12.00 [8.00, 17.00] 13.00 [9.00, 19.75] 0.06
ICU admission (%) 125 (79.6) 69 (73.4) 0.278
Invasive Ventilation (%) 54 (34.4) 12 (12.8) <0.001
Non-Invasive ventilation (BIPAP/HFNO) (%) 69 (43.9) 56 (59.6) 0.019
Face mask/O2 cannula (%) 34 (21.7) 25 (26.6) 0.442
Group C
Length of stay (median [IQR]) 8.00 [6.00, 12.00] 9.00 [7.00, 15.00] 0.193
ICU admission (%) 41 (46.1) 25 (49.0) 0.86
Invasive Ventilation (%) 5 (5.6) 5 (9.8) 0.497
Non-Invasive ventilation (BIPAP/HFNO) (%) 10 (11.2) 6 (11.8) 1
Face mask/O2 cannula (%) 50 (56.2) 26 (51.0) 0.599